The validity of current guidelines regarding surgical management of patients with gastric neuroendocrine neoplasms type 1: A report of a series of seven patients

Hormones

Volumn 12, Issue 4, 2013, Pages 517-521

  Boutzios, Georgios ^a   Griniatsos, John ^a   Dimitriou, Nikoletta ^a   Zilos, Athanassios ^a   Antoniou, Stavroula ^a   Felekouras, Evangelos ^a   Kaltsa, Gregory ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Enterochromaffin like cell hyperplasia; Gastric neuroendocrine neoplasms type 1; Gastric resection

Indexed keywords

CHROMOGRANIN A; GASTRIN;

ADULT; AGED; ATROPHIC GASTRITIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; GASTRECTOMY; GASTRIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; HYPERPLASIA; INFORMED CONSENT; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MALE; METAPLASIA; METASTASIS RESECTION; MIDDLE AGED; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PERI GASTRIC NEUROENDOCRINE NEOPLASM TYPE 1; POLYPECTOMY; PRACTICE GUIDELINE; PREOPERATIVE PERIOD; REVIEW; SPLENECTOMY; STOMACH ANTRUM RESECTION; STOMACH CANCER; SURGICAL TECHNIQUE; TUMOR INVASION;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROENDOCRINE TUMORS; PRACTICE GUIDELINES AS TOPIC; REOPERATION; REPRODUCIBILITY OF RESULTS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84891507733     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1439     Document Type: Review

References (15)

1. Gladdy RA, Strong VE, Coit D, et al, 2009 Defining surgical indications for type i gastric carcinoid tumor. Ann Surg oncol 16: 3154-3160.
2. Modlin IM, Lye KD, Kidd M, 2003 A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97: 934-959.
3. Niederle MB, Hackl M, Kaserer K, Niederle B, 2010 Astroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHo and european Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocrine-related cancer 17: 909-918.
4. Rindi G, Azzoni C, La rosa S, et al, 1999 Ecl cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116: 532-542.
5. Modlin IM, Lye KD, Kidd M, 2003 Carcinoid tumors of the stomach. Surg oncol 12: 153-172.
6. Rappel S, Altendorf-Hofmann A, Stolte M, 1995 Prognosis of gastric carcinoid tumours. Digestion 56: 455-462.
7. Ruszniewski P, Delle Fave G, Cadiot G, et al, 2006 Well-Differentiated gastric Tumors/ Carcinomas. Neu-roendocrinology 84: 158-164.
8. Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al, 2012 Enets Consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroen-docrinology 95 74-87.
9. Borch K, Ahren B, Ahlman H, 2005 Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Ann Surg 242: 64-73.
10. Manfredi S, Pagenault M, de Lajarte-Thirouard AS, Bretagne JF, 2007 Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue. Eur J gastroenterol Hepatol 19: 1021-1025.
11. Grozinsky-Glasberg S, Kaltsas G, Gur C, et al, 2008 Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours. Eur J endocrinol 159: 475-482.
12. Campana D, Nori F, Pezzilli R, et al, 2008 Gastric endocrine tumors type i: treatment with long-acting somatostatin analogs. Endocrrelat Cancer 15: 337-342.
13. Thomas D, Tsolakis AV, Grozinsky-Glasberg S, et al, 2012 Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors. Data from a mul-ticenter study. Eur J endocrinol. 168: 185-193.
14. Japanese gastric Cancer association, Japanese Classification of gastric Carcinoma, 2nd english edition 1998. Gastric Cancer 1: 10-24.
15. Modlin IM, Lye KD, Kidd M, 2004 A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J gastroenterol 99: 23-32.